HEADER TRANSPORT PROTEIN/ANTAGONIST 21-OCT-11 3UA8 TITLE CRYSTAL STRUCTURE ANALYSIS OF A 6-AMINO QUINAZOLINEDIONE SULFONAMIDE TITLE 2 BOUND TO HUMAN GLUR2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLUTAMATE RECEPTOR 2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: SEE REMARK 999; COMPND 5 SYNONYM: GLUR-2, AMPA-SELECTIVE GLUTAMATE RECEPTOR 2, GLUR-B, GLUR- COMPND 6 K2, GLUTAMATE RECEPTOR IONOTROPIC, AMPA 2, GLUA2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: GRIA2, GLUR2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: DE3; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PXI472D KEYWDS ION CHANNEL, IONIC CHANNEL, POSTSYNAPTIC MEMBRANE, TRANSMEMBRANE, KEYWDS 2 TRANSPORT PROTEIN-ANTAGONIST COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.KALLEN REVDAT 4 13-SEP-23 3UA8 1 REMARK SEQADV REVDAT 3 26-JUL-17 3UA8 1 SOURCE REMARK REVDAT 2 18-JAN-12 3UA8 1 JRNL REVDAT 1 11-JAN-12 3UA8 0 JRNL AUTH D.ORAIN,S.OFNER,M.KOLLER,D.A.CARCACHE,W.FROESTL,H.ALLGEIER, JRNL AUTH 2 V.RASETTI,J.NOZULAK,H.MATTES,N.SOLDERMANN,P.FLOERSHEIM, JRNL AUTH 3 S.DESRAYAUD,J.KALLEN,K.LINGENHOEHL,S.URWYLER JRNL TITL 6-AMINO QUINAZOLINEDIONE SULFONAMIDES AS ORALLY ACTIVE JRNL TITL 2 COMPETITIVE AMPA RECEPTOR ANTAGONISTS. JRNL REF BIOORG.MED.CHEM.LETT. V. 22 996 2012 JRNL REFN ISSN 0960-894X JRNL PMID 22197388 JRNL DOI 10.1016/J.BMCL.2011.12.009 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 3 NUMBER OF REFLECTIONS : 21296 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.185 REMARK 3 R VALUE (WORKING SET) : 0.184 REMARK 3 FREE R VALUE : 0.215 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1094 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.95 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1432 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.34 REMARK 3 BIN R VALUE (WORKING SET) : 0.1870 REMARK 3 BIN FREE R VALUE SET COUNT : 84 REMARK 3 BIN FREE R VALUE : 0.2480 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2016 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 30 REMARK 3 SOLVENT ATOMS : 244 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.63 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.15000 REMARK 3 B22 (A**2) : 0.25000 REMARK 3 B33 (A**2) : -0.10000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.163 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.141 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.085 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.815 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.941 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.924 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2085 ; 0.009 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 1438 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2812 ; 1.181 ; 1.986 REMARK 3 BOND ANGLES OTHERS (DEGREES): 3512 ; 0.811 ; 3.001 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 256 ; 5.543 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 82 ;34.603 ;24.146 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 392 ;13.411 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 11 ;15.378 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 308 ; 0.067 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2269 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 407 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1269 ; 0.590 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 528 ; 0.122 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2041 ; 1.146 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 816 ; 1.905 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 771 ; 3.224 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS REMARK 3 U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 3UA8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-OCT-11. REMARK 100 THE DEPOSITION ID IS D_1000068501. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-NOV-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.800 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21361 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 200 DATA REDUNDANCY : 10.90 REMARK 200 R MERGE (I) : 0.06200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.97 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.5 REMARK 200 DATA REDUNDANCY IN SHELL : 4.10 REMARK 200 R MERGE FOR SHELL (I) : 0.14100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 3R7X REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.42 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.25 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% W/V 2-PROPANOL, 10% W/V PEG4000, REMARK 280 100 MM HEPES, PH 7.5, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 25.59050 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 52.27400 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.59050 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 52.27400 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2450 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23430 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -13.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 102.36200 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 104.54800 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 413 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 1 REMARK 465 PRO A 2 REMARK 465 ASN A 3 REMARK 465 LYS A 4 REMARK 465 GLY A 262 REMARK 465 SER A 263 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 08W A 264 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3R7X RELATED DB: PDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 PROTEIN FRAGMENT CONSISTS OF UNP RESIDUES 413-527 CONNECTED TO UNP REMARK 999 RESIDUES 653-796 VIA AN ENGINEERED GT LINKER. DBREF 3UA8 A 3 117 UNP P42262 GRIA2_HUMAN 413 527 DBREF 3UA8 A 120 263 UNP P42262 GRIA2_HUMAN 653 796 SEQADV 3UA8 GLY A 1 UNP P42262 CLONING ARTIFACT SEQADV 3UA8 PRO A 2 UNP P42262 CLONING ARTIFACT SEQADV 3UA8 GLY A 118 UNP P42262 LINKER SEQADV 3UA8 THR A 119 UNP P42262 LINKER SEQRES 1 A 263 GLY PRO ASN LYS THR VAL VAL VAL THR THR ILE LEU GLU SEQRES 2 A 263 SER PRO TYR VAL MET MET LYS LYS ASN HIS GLU MET LEU SEQRES 3 A 263 GLU GLY ASN GLU ARG TYR GLU GLY TYR CYS VAL ASP LEU SEQRES 4 A 263 ALA ALA GLU ILE ALA LYS HIS CYS GLY PHE LYS TYR LYS SEQRES 5 A 263 LEU THR ILE VAL GLY ASP GLY LYS TYR GLY ALA ARG ASP SEQRES 6 A 263 ALA ASP THR LYS ILE TRP ASN GLY MET VAL GLY GLU LEU SEQRES 7 A 263 VAL TYR GLY LYS ALA ASP ILE ALA ILE ALA PRO LEU THR SEQRES 8 A 263 ILE THR LEU VAL ARG GLU GLU VAL ILE ASP PHE SER LYS SEQRES 9 A 263 PRO PHE MET SER LEU GLY ILE SER ILE MET ILE LYS LYS SEQRES 10 A 263 GLY THR PRO ILE GLU SER ALA GLU ASP LEU SER LYS GLN SEQRES 11 A 263 THR GLU ILE ALA TYR GLY THR LEU ASP SER GLY SER THR SEQRES 12 A 263 LYS GLU PHE PHE ARG ARG SER LYS ILE ALA VAL PHE ASP SEQRES 13 A 263 LYS MET TRP THR TYR MET ARG SER ALA GLU PRO SER VAL SEQRES 14 A 263 PHE VAL ARG THR THR ALA GLU GLY VAL ALA ARG VAL ARG SEQRES 15 A 263 LYS SER LYS GLY LYS TYR ALA TYR LEU LEU GLU SER THR SEQRES 16 A 263 MET ASN GLU TYR ILE GLU GLN ARG LYS PRO CYS ASP THR SEQRES 17 A 263 MET LYS VAL GLY GLY ASN LEU ASP SER LYS GLY TYR GLY SEQRES 18 A 263 ILE ALA THR PRO LYS GLY SER SER LEU ARG ASN ALA VAL SEQRES 19 A 263 ASN LEU ALA VAL LEU LYS LEU ASN GLU GLN GLY LEU LEU SEQRES 20 A 263 ASP LYS LEU LYS ASN LYS TRP TRP TYR ASP LYS GLY GLU SEQRES 21 A 263 CYS GLY SER HET 08W A 264 30 HETNAM 08W N-METHYL-1-{3-[(METHYLSULFONYL)AMINO]-2,4-DIOXO-7- HETNAM 2 08W (TRIFLUOROMETHYL)-1,2,3,4-TETRAHYDROQUINAZOLIN-6-YL}- HETNAM 3 08W 1H-IMIDAZOLE-4-CARBOXAMIDE FORMUL 2 08W C15 H13 F3 N6 O5 S FORMUL 3 HOH *244(H2 O) HELIX 1 1 ASN A 22 LEU A 26 5 5 HELIX 2 2 GLU A 27 GLU A 30 5 4 HELIX 3 3 GLY A 34 GLY A 48 1 15 HELIX 4 4 ASN A 72 TYR A 80 1 9 HELIX 5 5 THR A 93 GLU A 98 1 6 HELIX 6 6 SER A 123 LYS A 129 1 7 HELIX 7 7 GLY A 141 SER A 150 1 10 HELIX 8 8 ILE A 152 ALA A 165 1 14 HELIX 9 9 THR A 173 SER A 184 1 12 HELIX 10 10 SER A 194 GLN A 202 1 9 HELIX 11 11 LEU A 230 GLN A 244 1 15 HELIX 12 12 GLY A 245 TYR A 256 1 12 SHEET 1 A 3 TYR A 51 ILE A 55 0 SHEET 2 A 3 VAL A 6 THR A 10 1 N VAL A 8 O THR A 54 SHEET 3 A 3 ILE A 85 ALA A 86 1 O ILE A 85 N THR A 9 SHEET 1 B 2 MET A 18 MET A 19 0 SHEET 2 B 2 TYR A 32 GLU A 33 -1 O GLU A 33 N MET A 18 SHEET 1 C 2 ILE A 100 PHE A 102 0 SHEET 2 C 2 ALA A 223 PRO A 225 -1 O THR A 224 N ASP A 101 SHEET 1 D 2 MET A 107 LEU A 109 0 SHEET 2 D 2 LYS A 218 TYR A 220 -1 O LYS A 218 N LEU A 109 SHEET 1 E 4 ALA A 134 GLY A 136 0 SHEET 2 E 4 TYR A 188 GLU A 193 1 O LEU A 191 N GLY A 136 SHEET 3 E 4 ILE A 111 LYS A 116 -1 N MET A 114 O TYR A 190 SHEET 4 E 4 THR A 208 VAL A 211 -1 O VAL A 211 N ILE A 113 SSBOND 1 CYS A 206 CYS A 261 1555 1555 2.03 CISPEP 1 SER A 14 PRO A 15 0 -1.30 CISPEP 2 GLU A 166 PRO A 167 0 -3.88 CISPEP 3 LYS A 204 PRO A 205 0 5.78 SITE 1 AC1 19 GLU A 13 TYR A 16 TYR A 61 PRO A 89 SITE 2 AC1 19 LEU A 90 THR A 91 ARG A 96 THR A 174 SITE 3 AC1 19 GLU A 193 MET A 196 TYR A 220 HOH A 267 SITE 4 AC1 19 HOH A 286 HOH A 290 HOH A 307 HOH A 416 SITE 5 AC1 19 HOH A 433 HOH A 448 HOH A 483 CRYST1 51.181 104.548 49.441 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019539 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009565 0.000000 0.00000 SCALE3 0.000000 0.000000 0.020226 0.00000